Check out the companies which will be in focus during trade today based on recent and latest news developments.
Sun Pharmaceutical Industries Ltd: Sun Pharma announced that as a part of its manufacturing consolidation in the US, one of its wholly owned subsidiaries has entered into an agreement with Frontida BioPharma.
Excel Crop: Sumitomo has acquired 44.98% stake in Excel Crop Care for around Rs. 623.44 crore, says report.The company also announced launch of Rs.415.80 crore open offer to acquire further 30 per cent stake in the company.
Gammon India Ltd: The company said its board has approved amendment to an agreement signed with its arm Gammon Retail Infrastructure for transfer of EPC business.
Zydus Cadila: Zydus Cadila has received approval from the US health regulator to initiate a phase II clinical trial of Saroglitazar in patients with non-alcoholic steatohepatitis (NASH) of the liver.
Yes Bank: Yes Bank is planning to raise USD 1 billion from overseas investors in the current fiscal as it has recently got government approval for increasing foreign investment to 74 per cent, says report.
Biocon: Mylan and Biocon Ltd announced the presentation of data from the HERITAGE study at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, June 3-7. The study confirmed the efficacy, safety and immunogenicity of MYL-1401O, the proposed biosimilar trastuzumab co-developed by Biocon and Mylan, in comparison to branded trastuzumab.
Adani Enterprise Ltd: Adani Enterprise may walk away from its proposal to build one of the world's biggest coal mines in Australia, says report.
Lupin: Lupin is planning to launch up to 30 drugs in the US market in the current fiscal, says report.
Indiabulls Real Estate: The company has announced that Tapir Realty Developers Ltd, a 100% subsidiary of the company, has entered into a joint development agreement with Oricon Properties.
Natco Pharma: The company received US Food and Drug Administration (USFDA) approval for Abbreviated New Drug Application (ANDA) for a cancer drug.
Force Motors: Force Motors has announced its sales performance for the month of May 2016. The company sold 1,588 SCV, LCVs & 923 UV, SUV Tractors in May 2016.
Gujarat Industries Power Company Ltd: The company has informed BSE that on account of financial difficulties faced by Leitwind Shriram Manufacturing Ltd., Chennai, the EPC Contractor, the date of commissioning of the 51 MW Wind based Power Project in Gujarat has been delayed.
Kwality: KKR India is set to invest about Rs.600 crore in Kwality Ltd, as per media report. KKR India will invest through a structured debt transaction.
Jubilant Life Sciences Ltd: The company has received ANDA final approval for Levetiracetam Injection USP, 500 mg/5 mL (100 mg/mL), the generic version of Keppra Injection 500mg/5mL (100mg/mL) of UCB, which is used for the treatment of epilepsy.
Oriental Bank of Commerce: The bank is planning for a credit growth of 12% in the current fiscal with focus on retail and SME lending.
Vakrangee: Vakrangee announce Corporate Agency tie up with CIGNA TTK Health Insurance Company issued by Insurance Regulatory Development Authority of India to distribute Health Insurance product through Vakrangee distribution network.
Sun Pharmaceutical Industries Ltd: Sun Pharma announced that as a part of its manufacturing consolidation in the US, one of its wholly owned subsidiaries has entered into an agreement with Frontida BioPharma.Excel Crop: Sumitomo has acquired 44.98% stake in Excel Crop Care for around Rs. 623.44 crore, says report.The company also announced launch of Rs.415.80 crore open offer to acquire further 30 per cent stake in the company.
Gammon India Ltd: The company said its board has approved amendment to an agreement signed with its arm Gammon Retail Infrastructure for transfer of EPC business.
Zydus Cadila: Zydus Cadila has received approval from the US health regulator to initiate a phase II clinical trial of Saroglitazar in patients with non-alcoholic steatohepatitis (NASH) of the liver.
Yes Bank: Yes Bank is planning to raise USD 1 billion from overseas investors in the current fiscal as it has recently got government approval for increasing foreign investment to 74 per cent, says report.
Biocon: Mylan and Biocon Ltd announced the presentation of data from the HERITAGE study at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, June 3-7. The study confirmed the efficacy, safety and immunogenicity of MYL-1401O, the proposed biosimilar trastuzumab co-developed by Biocon and Mylan, in comparison to branded trastuzumab.
Adani Enterprise Ltd: Adani Enterprise may walk away from its proposal to build one of the world's biggest coal mines in Australia, says report.
Lupin: Lupin is planning to launch up to 30 drugs in the US market in the current fiscal, says report.
Indiabulls Real Estate: The company has announced that Tapir Realty Developers Ltd, a 100% subsidiary of the company, has entered into a joint development agreement with Oricon Properties.
Natco Pharma: The company received US Food and Drug Administration (USFDA) approval for Abbreviated New Drug Application (ANDA) for a cancer drug.
Force Motors: Force Motors has announced its sales performance for the month of May 2016. The company sold 1,588 SCV, LCVs & 923 UV, SUV Tractors in May 2016.
Gujarat Industries Power Company Ltd: The company has informed BSE that on account of financial difficulties faced by Leitwind Shriram Manufacturing Ltd., Chennai, the EPC Contractor, the date of commissioning of the 51 MW Wind based Power Project in Gujarat has been delayed.
Kwality: KKR India is set to invest about Rs.600 crore in Kwality Ltd, as per media report. KKR India will invest through a structured debt transaction.
Jubilant Life Sciences Ltd: The company has received ANDA final approval for Levetiracetam Injection USP, 500 mg/5 mL (100 mg/mL), the generic version of Keppra Injection 500mg/5mL (100mg/mL) of UCB, which is used for the treatment of epilepsy.
Oriental Bank of Commerce: The bank is planning for a credit growth of 12% in the current fiscal with focus on retail and SME lending.
Vakrangee: Vakrangee announce Corporate Agency tie up with CIGNA TTK Health Insurance Company issued by Insurance Regulatory Development Authority of India to distribute Health Insurance product through Vakrangee distribution network.
No comments:
Post a Comment